ANTIBIOTIKLARGA CHIDAMLILIK MUAMMOSIGA QARSHI YANGI ANTIMIKROB PREPARATLARNING ISHLAB CHIQILISHI
Keywords:
antibiotiklarga chidamlilik, antimikrob preparatlar, yangi antibiotiklar, bakteriofag terapiyasi, nanotexnologiya, sun’iy intellect, ko‘p rezistent bakteriyalarAbstract
Antibiotiklarga chidamlilik (AMR) global sog‘liqni saqlash sohasidagi jiddiy muammo bo‘lib, yangi antimikrob preparatlar ishlab chiqishni talab qiladi. Ushbu maqola AMRga qarshi yangi antibiotiklar, sun’iy intellekt yordamida kashf etilgan birikmalar, bakteriofag terapiyasi va nanotexnologiya kabi innovatsion yondashuvlarni tizimli adabiyotlar tahlili asosida ko‘rib chiqadi. Natijalar yangi preparatlarning yuqori potentsialini, ammo xarajatlar, tez chidamlilik va regulyator to‘siqlar kabi cheklovlarni ko‘rsatdi. Xalqaro hamkorlik, “One Health” yondashuvi va antibiotiklardan oqilona foydalanish AMRni bartaraf etishda muhimdir. Maqola kelajakdagi tadqiqotlar uchun yo‘nalishlarni taklif qiladi.
References
1. Kortright, K. E., Chan, B. K., Koff, J. L., & Turner, P. E. (2019). Phage therapy: A renewed approach to combat antibiotic-resistant bacteria. Cell Host & Microbe, 25(2), 219–232. https://doi.org/10.1016/j.chom.2019.01.014
2. O'Neill, Jim. "Tackling drug-resistant infections globally: final report and recommendations." (2016): 84-pp.
3. Pew Charitable Trusts. (2020). Tracking the global pipeline of antibiotics in development. https://www.pewtrusts.org/en/research-and-analysis/reports/2020/03/tracking-the-global-pipeline-of-antibiotics-in-development
4. Singer, Andrew C., Claas Kirchhelle, and Adam P. Roberts. "(Inter) nationalising the antibiotic research and development pipeline." The Lancet Infectious Diseases 20.2 (2020): e54-e62.
5. Stokes, J. M., Yang, K., Swanson, K., Jin, W., Cubillos-Ruiz, A., Donghia, N. M., ... & Collins, J. J. (2020). A deep learning approach to antibiotic discovery. Cell, 180(4), 688–702. https://doi.org/10.1016/j.cell.2020.01.021
6. Rossolini, Gian Maria, et al. "Update on the antibiotic resistance crisis." Current opinion in pharmacology 18 (2014): 56-60.
7. Ventola, C. L. (2015). The antibiotic resistance crisis: Part 1: Causes and threats. Pharmacy and Therapeutics, 40(4), 277–283. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378521/
8. Wang, Linlin, Chen Hu, and Longquan Shao. "The antimicrobial activity of nanoparticles: present situation and prospects for the future." International journal of nanomedicine (2017): 1227-1249.
9. Wong, Darren, and David Van Duin. "Novel beta-lactamase inhibitors: unlocking their potential in therapy." Drugs 77.6 (2017): 615-628.
10. World Health Organization. (2019). Antimicrobial resistance: Global report on surveillance. https://www.who.int/publications/i/item/9789241565615
